Cefixime for Oral Suspension USP
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Most common reason: Impurity / degradation (6 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Cefixime. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Failed Content Uniformity Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed impurities/degradation specifications
Failed Impurities/Degradation Specifications
Subpotent Drug
Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Discoloration; Product may not meet specifications for color description once reconstituted.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.